P4A Let's Talk Rare: The Life Science Podcast
Episodes
Weekly Roundup: July 17, 2018
17 Jul 2018
Contributed by Lukas
The U.S. FDA's new guidance on gene therapy was recently announced by FDA Commissioner Dr. Scott Gottlieb, the P4A team discuss key implications of th...
Weekly Roundup: July 11, 2018
11 Jul 2018
Contributed by Lukas
This week, the team discuss the U.S. Centres for Medicare & Medicaid Services withdrawing support for a novel payment model for Novartis' Kymriah; Pfi...
Weekly Roundup: July 4, 2018
04 Jul 2018
Contributed by Lukas
This week, the P4A team discuss the CHMP approval of two CAR-T Therapies; Scotland's new rules for ultra-orphan drugs and the reaction to the announce...
Weekly Roundup: June 26, 2018
26 Jun 2018
Contributed by Lukas
This week, the P4A team delve into the pharma industry's proposal to the EU on the role of national HTA bodies post harmonization of clinical assessme...
Weekly Roundup: June 19, 2018
19 Jun 2018
Contributed by Lukas
The P4A team give a summary of the gene therapy FDA news this week and also discuss President Trump's drug pricing plans for Medicare and UK cost watc...
Weekly Roundup: June 12, 2018
12 Jun 2018
Contributed by Lukas
This week's episode discusses the EU's research and innovation budget; Italy's AIFA responding to physician criticism of new guidelines and Oxford Bio...
Weekly Roundup: June 5, 2018
05 Jun 2018
Contributed by Lukas
This week the P4A team discuss key advancements in oncology treatments - a genetic test indicating whether chemotherapy is beneficial in a particular ...
Weekly Roundup: May 31, 2018
31 May 2018
Contributed by Lukas
In its very first podcast of Rare Disease, Cell & Gene Therapy Weekly RoundUp, P4A discusses the US FDA's accelerated regulatory process for gene ther...